Limited Offer
Pancreatic Cancer, An Issue of Hematology/Oncology Clinics of North America
- 1st Edition, Volume 36-5 - October 20, 2022
- Editors: Matthew B. Yurgelun, Douglas A. Rubinson
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 9 8 6 5 5 - 7
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 8 6 5 6 - 4
In this issue of Hematology/Oncology Clinics, guest editors Drs. Matthew B. Yurgelun and Douglas A. Rubinson bring their considerable expertise to the topic of Pancreatic Cancer.… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quote-
Contains 14 relevant, practice-oriented topics including diabetes, cachexia, sarcopenia, and metabolic factors in individuals with pancreatic adenocarcinoma; PARP inhibitors and other novel therapeutics in pancreatic adenocarcinoma; screening and surveillance for pancreatic adenocarcinoma in high-risk individuals; germline testing for individuals with pancreatic adenocarcinoma and novel genetic risk factors; and more.
-
Provides in-depth clinical reviews on pancreatic cancer, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Preface
- Pancreatic Adenocarcinoma: Trends in Epidemiology, Risk Factors, and Outcomes
- Key points
- Introduction
- Summary
- Clinics care points
- The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes
- Key points
- Introduction
- Pathophysiology and preclinical pancreatic ductal adenocarcinoma cachexia models
- Cachexia, muscle wasting and adiposity-related clinical outcomes in pancreatic ductal adenocarcinoma
- Assessment and management considerations for pancreatic ductal adenocarcinoma cachexia
- Summary
- Clinics care points
- What Can We Learn About Pancreatic Adenocarcinoma from Imaging?
- Key points
- Introduction
- Imaging
- Guidelines
- Approach
- Summary
- Clinics care points
- Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals
- Key points
- Introduction
- Assessment of pancreatic ductal adenocarcinoma risk
- Candidates for pancreatic ductal adenocarcinoma surveillance
- Targets and goals of surveillance
- Current approaches to pancreatic cancer surveillance
- Additional recommendations for high-risk individuals
- Potential harms
- Future directions
- Summary
- Clinics care points
- Germline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk Factors
- Key points
- Current guidelines for germline genetic testing of pancreatic ductal adenocarcinoma susceptibility genes
- Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma
- Key points
- Introduction
- History of adjuvant care
- Role of surgical resection
- Localized pancreatic adenocarcinoma
- Perioperative management
- Summary
- Clinics care points
- Author contributions
- Funding
- Disclosure
- Novel Considerations in Surgical Management of Individuals with Pancreatic Adenocarcinoma
- Key points
- Introduction
- Clinical presentation and diagnostic workup
- Management of operable pancreatic cancer
- Expanding surgical selection
- Summary
- Clinics care points
- Radiotherapy for Pancreatic Adenocarcinoma: Recent Developments and Advances on the Horizon
- Key points
- Introduction
- Summary
- Clinics care points
- Cytotoxic Chemotherapy in Advanced Pancreatic Cancer
- Key points
- Introduction
- First-line therapy
- Second-line therapy
- Summary
- Clinics care points
- PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma
- Key points
- Introduction
- Poly-ADP ribose polymerase inhibitors
- Predictive biomarkers of poly-ADP ribose polymerase inhibitor in pancreatic ductal adenocarcinoma
- Future directions for poly-ADP ribose polymerase inhibitor in pancreatic ductal adenocarcinoma
- NTRK fusions
- Neuregulin 1 fusions
- Mismatch repair deficiency in pancreatic ductal adenocarcinoma
- KRAS G12C mutations
- Summary
- Clinics care points
- Genetics of Pancreatic Neuroendocrine Tumors
- Key points
- Introduction
- Somatic mutations in patients with pancreatic neuroendocrine tumors
- Genes related to the mammalian target of rapamycin
- Potential clinical utility of somatic testing in patients with neuroendocrine tumors
- Germline mutations in patients with pancreas neuroendocrine tumors
- Others
- Potential clinical utility of germline testing in patients with neuroendocrine tumors
- Summary
- Clinics care points
- Palliative and Supportive Care for Individuals with Pancreatic Adenocarcinoma
- Key points
- Palliative and supportive care needs for individuals with pancreatic adenocarcinoma
- Palliative and supportive care services in oncology
- Benefits of palliative and supportive care interventions in oncology
- Data regarding palliative and supportive care in pancreatic adenocarcinoma
- Future directions for palliative and supportive care in pancreatic adenocarcinoma
- Clinics care points
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 36-5
- Published: October 20, 2022
- Imprint: Elsevier
- Hardback ISBN: 9780323986557
- eBook ISBN: 9780323986564
MY
Matthew B. Yurgelun
DR